{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-113265","form_type":"8-K","ticker":"HCWB","cik":"0001828673","company_name":"HCW Biologics Inc.","filed_at":"2025-09-05T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.184209+00:00","generated_at":"2026-05-17T08:04:01.472992+00:00","sec_items":["1.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"HCW Biologics says licensee WY Biotech will likely miss $7M upfront payment; negotiations ongoing","bullets":["WY Biotech likely won't meet Sept 30, 2025 deadline for $7.0M upfront license fee under exclusive agreement.","WY Biotech has not finalized CDMO and investor agreements, delaying payment as previously reported.","Company and WY Biotech are negotiating potential further revisions and additions to the license agreement.","Delay follows earlier extension from July 18, 2025; no revised payment date has been set."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-113265","json":"https://secwatch.observer/filing/0000950170-25-113265.json","markdown":"https://secwatch.observer/filing/0000950170-25-113265.md","text":"https://secwatch.observer/filing/0000950170-25-113265.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1828673/000095017025113265/0000950170-25-113265-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1828673/000095017025113265/hcwb-20250902.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T08:04:01.472992+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}